Medtronic puts Avecor in perfusion division:
This article was originally published in Clinica
Medtronic has completed its acquisition of Avecor Cardiovascular, which is to be incorporated into Medtronic's reorganised perfusion systems division. The unit includes Medtronic's blood management and cardiopulmonary business. Medtronic says the combined businesses will provide the leading cardiac surgery perfusion product line. Medtronic was forced to increase its bid for Avecor from $11.125 per share to $13 each after the Minneapolis-based company received an offer of $13 from an unnamed third-party (see Clinica No 838, p 10).